
Fluticasone Furoate + Vilanterol Suppliers & Bulk Manufacturers
Available Forms: Powder For Inhalation(DPI/MDI)
Available Strengths: 92 mcg Fluticasone furoate / 22 mcg Vilanterol; 184 mcg Fluticasone furoate / 22 mcg Vilanterol
Reference Brands: Breo Ellipta®(US), Relvar Ellipta® (EU)
Category: Respiratory Disorder
Fluticasone furoate + Vilanterol is available in Powder For Inhalation(DPI/MDI) and strengths such as 92 mcg Fluticasone furoate / 22 mcg Vilanterol; 184 mcg Fluticasone furoate / 22 mcg Vilanterol. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Fluticasone furoate + Vilanterol is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
Technical Specifications & Supply Details | |
---|---|
Lead Time | 7 to 60 days (depending on batch size & schedule) |
MOQ | As per manufacturer’s batch size |
COA | Available with every batch |
Regulatory Dossier / DMF | Available upon request |
Export Documentation | FSC, COA, Manufacturing License, Product Permission |
Standards | IP, BP, USP |
Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Fluticasone furoate + Vilanterol can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Product Description: Fluticasone furoate and Vilanterol is a powerful once-daily combination therapy used for the long-term treatment of asthma and chronic obstructive pulmonary disease (COPD). Marketed as Breo Ellipta® in the U.S. and Relvar Ellipta® in the EU, this inhalation powder combines Fluticasone, a corticosteroid that reduces inflammation, with Vilanterol, a long-acting beta-agonist (LABA) that relaxes airway muscles. Available in 92/22 mcg and 184/22 mcg strengths via the Ellipta® DPI, it offers 24-hour symptom control. Ideal for pharma B2B and export markets, this therapy enhances adherence and delivers effective respiratory relief with convenient once-daily dosing.
Frequently Asked Questions
Related Products
Mometasone + Formoterol
Strength: 100 mcg/5 mcg , 200 mcg/5 mcg
Form: Inhaler(MDI)
Reference Brands: Dulera®(US)
View DetailsAmbroxol Hydrochloride
Strength: Tab: 30 mg, 60 mg; Syrup: 15 mg/5 mL, 30 mg/5 mL; Drops: 7.5 mg/mL, 15 mg/mL
Form: Tablets, Syrup & Oral drops
Reference Brands: Mucosolvan®, Flavamed®, Ambrobeta®, Ambroxol-ratiopharm®(EU)
View DetailsCarbocisteine
Strength: Cap: 375 mg and 750 mg; Oral Solution: 50 mg/5 mL and 750 mg/5 mL
Form: Capsules, Oral Solutions/Syrups
Reference Brands: Mucodyne, Lisomucil®, Rhinathiol®, Muciclar®, Actithiol®, Mucolex®(US)
View DetailsTriprolidine Hcl + Pseudoephedrine Hcl
Strength: Tab: 2.5 mg/60 mg; Oral Solution: 0.5 mg/mL, 0.625 mg/mL, 0.938 mg/mL, and 1.25 mg/mL
Form: Tablet & Oral solution
Reference Brands: Histex®, Vanahist PD®, M-Hist PD®, PediaClear®, Aprodine®, Zymine®, Allerfrim®, ENDAL®
View DetailsQuick Response Guaranteed | Verified Suppliers